CLOV vs IRWD · rev $1.37B vs P/E 5.7, rev $90.5M
Clover Health Investments Corp (CLOV) versus Ironwood Pharmaceuticals Inc (IRWD) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IRWD revenue for 2024-12-31 was $90.5M. Net income was $2.3M. Revenue was down 1.1% from 2024-09-30 to 2024-12-31. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
CLOV currently screens at market cap $1.55B. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Not investment advice. Open the CLOV and IRWD stock pages for the full models.
Not investment advice.